Crossmark

Effective calcineurin inhibitor treatment in adult-onset steroid-resistant nephrotic syndrome with a novel splice donor site variant of TRPC6: a case report

Crossref DOI link: https://doi.org/10.1007/s13730-024-00935-6

Published Online: 2024-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagasaka, Tomoki

Uchiyama, Kiyotaka https://orcid.org/0000-0002-5173-1263
Hama, Eriko Yoshida

Kojima, Daiki

Kaneko, Kenji

Yoshimoto, Norifumi

Yasuda, Itaru

Yamada, Mamiko

Miya, Fuyuki

Suzuki, Hisato

Tajima, Takaya

Yamaguchi, Shintaro

Hayashi, Kaori

Kanda, Takeshi

Hashiguchi, Akinori

Kosaki, Kenjiro

Itoh, Hiroshi
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP24ek0109672, JP24ek0109760)
License Information

Text and Data Mining valid from 2024-09-30

Version of Record valid from 2024-09-30
More Information

Article History

Received: 4 April 2023

Accepted: 23 September 2024

First Online: 30 September 2024

Declarations

:

: The authors have declared that no conflict of interest exists.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number 20,110,262) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

: Written informed consent to the publication of this case report was obtained from the patient.

Document is current

Any future updates will be listed below